Keyword: BioClinica


Executive Summary: Investigator Site Payments Strategy Survey

As the number of clinical trials increases so does the complexity and number of US and global sites needed to foster trial success. Read what was discovered after a survey on current site payment practices, how these practices are measured, what process improvement initiatives are currently being explored, what are some of the barriers to change, and what site payment trends will occur over the next five years. Download it now!

After $160M Medpace IPO, Cinven buys Bioclinica

The $14 billion deal that will see Pfizer buy out Californian cancer biotech Medivation might be hitting the headlines this week, but after weeks of speculation the clinical trial services firm Bioclinica has now seen a major merger of its own.